| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0952-7915(01)00277-1 |
| P698 | PubMed publication ID | 11677088 |
| P2093 | author name string | Kunkel SL | |
| Godessart N | |||
| P2860 | cites work | Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis | Q73904635 |
| Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue | Q74016845 | ||
| Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent | Q74165253 | ||
| Chemokine expression and leucocyte infiltration in Sjögren's syndrome | Q77134267 | ||
| Association of rheumatoid arthritis with a functional chemokine receptor, CCR5 | Q77738649 | ||
| Acute and relapsing experimental autoimmune encephalomyelitis are regulated by differential expression of the CC chemokines macrophage inflammatory protein-1alpha and monocyte chemotactic protein-1 | Q77900081 | ||
| Cytokine, activation marker, and chemokine receptor expression by individual CD4(+) memory T cells in rheumatoid arthritis synovium | Q24792676 | ||
| The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8) | Q24792930 | ||
| Synovial stromal cells from rheumatoid arthritis patients attract monocytes by producing MCP-1 and IL-8 | Q24793032 | ||
| Cell-cell interactions in synovitis. Interactions between T cells and B cells in rheumatoid arthritis | Q24805154 | ||
| CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis | Q28587371 | ||
| Chemokines: a new classification system and their role in immunity | Q29615663 | ||
| Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains | Q31838764 | ||
| Depletion of CCR5-expressing cells with bispecific antibodies and chemokine toxins: a new strategy in the treatment of chronic inflammatory diseases and HIV. | Q31838971 | ||
| Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? | Q33937489 | ||
| Chemokines in autoimmune diseases | Q34118811 | ||
| Update on synovitis | Q34140984 | ||
| C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis | Q35126948 | ||
| Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. | Q36368947 | ||
| Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism | Q39906436 | ||
| Bonzo/CXCR6 expression defines type 1-polarized T-cell subsets with extralymphoid tissue homing potential | Q39907271 | ||
| Design, synthesis, and discovery of a novel CCR1 antagonist | Q40811774 | ||
| Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. | Q40856416 | ||
| Lymph draining from foot joints in rheumatoid arthritis provides insight into local cytokine and chemokine production and transport to lymph nodes | Q43550720 | ||
| Serum and CSF levels of MCP-1 and IP-10 in multiple sclerosis patients with acute and stable disease and undergoing immunomodulatory therapies | Q43562152 | ||
| Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis | Q43607170 | ||
| Effective antigen-specific immunotherapy in the marmoset model of multiple sclerosis | Q49071851 | ||
| Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. | Q52023146 | ||
| Differential expression of CC chemokines and the CCR5 receptor in the pancreas is associated with progression to type I diabetes. | Q54045893 | ||
| Aberrant T cell migration toward RANTES and MIP-1 alpha in patients with multiple sclerosis. Overexpression of chemokine receptor CCR5. | Q54513553 | ||
| CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells | Q58064340 | ||
| SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS | Q58205027 | ||
| RANTES production and expression is reduced in relapsing-remitting multiple sclerosis patients treated with interferon-β-1b | Q59389234 | ||
| A Common Stromal Cell-Derived Factor-1 Chemokine Gene Variant is Associated With the Early Onset of Type 1 Diabetes | Q60609053 | ||
| CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosis | Q63728112 | ||
| Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions | Q73223366 | ||
| Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta | Q73276269 | ||
| Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients | Q73311968 | ||
| CXCR3 and CCR5 ligands in rheumatoid arthritis synovium | Q73352970 | ||
| Regulation of angiogenesis by the C-X-C chemokines interleukin-8 and epithelial neutrophil activating peptide 78 in the rheumatoid joint | Q73521731 | ||
| "Lymphoid" chemokine messenger RNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation | Q73565836 | ||
| P433 | issue | 6 | |
| P921 | main subject | autoimmune disease | Q8084905 |
| P304 | page(s) | 670-675 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | Current Opinion in Immunology | Q15752917 |
| P1476 | title | Chemokines in autoimmune disease | |
| P478 | volume | 13 |
| Q35158048 | A potential role for CXCR3 chemokines in the response to ocular HSV infection |
| Q34345236 | An IP-10 (CXCL10)-derived peptide inhibits angiogenesis |
| Q47980681 | Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behçet's disease |
| Q88750056 | Associations between CCL21 gene polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis |
| Q37085790 | CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice |
| Q58845623 | CCR5 plays a critical role in the development of myocarditis and host protection in mice infected with Trypanosoma cruzi |
| Q54688004 | CCR5-Delta32: implications in SLE development. |
| Q48328342 | CD83-positive dendritic cells are present in occasional perivascular cuffs in multiple sclerosis lesions. |
| Q51817387 | CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. |
| Q37959331 | Cellular and molecular mechanisms of autoimmune disease |
| Q54745308 | Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritis. |
| Q35048804 | Chemokine receptors in inflammation: an overview |
| Q35126970 | Chemokines and antitumor immunity: walking the tightrope |
| Q33964919 | Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease |
| Q37594837 | Chemokines and chemokine receptors in multiple sclerosis |
| Q36734084 | Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies |
| Q35172075 | Chemokines in autoimmunity: from pathology to therapeutics |
| Q49634148 | Chemokines in homeostasis and diseases |
| Q35553416 | Chemokines in joint disease: the key to inflammation? |
| Q88173246 | Chemokines: the past, the present and the future |
| Q50096567 | Control of Salmonella dissemination in vivo by macrophage inflammatory protein (MIP)-3alpha/CCL20. |
| Q34016146 | Copy number variation in the human genome and its implication in autoimmunity |
| Q44757991 | Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease |
| Q88085980 | Distinct Regulation of CXCL10 Production by Cytokines in Human Salivary Gland Ductal and Acinar Cells |
| Q39017722 | G protein coupled receptors signaling pathways implicate in inflammatory and immune response of rheumatoid arthritis |
| Q24806177 | Homing chemokines in rheumatoid arthritis. |
| Q81683808 | Hormone regulation of microglial cell activation: relevance to multiple sclerosis |
| Q37107209 | Immunomodulatory effects of therapeutic plasma exchange on monocytes in antiphospholipid syndrome. |
| Q36059965 | Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models |
| Q33766726 | Inhibitor of DNA binding 1 as a secreted angiogenic transcription factor in rheumatoid arthritis |
| Q41728362 | Insights into the binding modes of CC chemokine receptor 4 (CCR4) inhibitors: a combined approach involving homology modelling, docking, and molecular dynamics simulation studies |
| Q28677042 | Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn's disease |
| Q24647107 | Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes |
| Q50902178 | Lipopolysaccharide accelerates collagen-induced arthritis in association with rapid and continuous production of inflammatory mediators and anti-type II collagen antibody. |
| Q39063424 | Microfluidic transwell inserts for generation of tissue culture-friendly gradients in well plates |
| Q62898463 | Oral Lichen Planus |
| Q21342822 | PPAR-gamma: Therapeutic Potential for Multiple Sclerosis |
| Q35205460 | Pain and the blood-brain barrier: obstacles to drug delivery |
| Q36744611 | Pathogenesis of autoimmune hepatitis: from break of tolerance to immune-mediated hepatocyte apoptosis |
| Q36392735 | Peptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1. |
| Q41603563 | Pharmacological blockade of CCR1 ameliorates murine arthritis and alters cytokine networks in vivo |
| Q28262774 | Plasma biomarkers discriminate clinical forms of multiple sclerosis |
| Q38109821 | Recent developments in microfluidics-based chemotaxis studies |
| Q35553478 | Role of tumour necrosis factor (TNF) in host defence against tuberculosis: implications for immunotherapies targeting TNF |
| Q79365076 | Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares |
| Q33757547 | Still waiting for the end. The promise of genomics and proteomics for autoimmune diseases |
| Q81634736 | T cell costimulation by chemokine receptors |
| Q44452432 | TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis |
| Q30333360 | The CC chemokine CCL20 and its receptor CCR6. |
| Q24337078 | The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization |
| Q33685257 | The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease |
| Q33624382 | The role of chemokines in Guillain-Barré syndrome |
| Q36992526 | The role of chemokines in leucocyte-stromal interactions in rheumatoid arthritis |
| Q42116282 | Therapy for pneumonitis and sialadenitis by accumulation of CCR2-expressing CD4+CD25+ regulatory T cells in MRL/lpr mice |
| Q35111832 | Upcoming biologic agents for the treatment of rheumatic diseases |
| Q51715586 | Use of Resonance Energy Transfer Techniques for In Vivo Detection of Chemokine Receptor Oligomerization. |
| Q34426246 | Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy |
Search more.